Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Retinal Vein Occlusion as a Marker of Systemic Risk
Ashkan Abbey, MD
Ischemic vs. Non-Ischemic RVO: How Do You Know?
Jessica Randolph, MD
Retinal Vein Occlusion in Younger Patients: Key Care Considerations
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
At the Lid Line: Unmasking Demodex Across the OSD Spectrum
Closing the Loop: Structured Follow-Up and Patient Communication
Sustained-Release Drug Delivery for Early-Stage Glaucoma
Lorraine M. Provencher, MD
Zarmeena Vendal
Inder Paul Singh
Manjool Shah, MD
Emily Schehlein, MD
Swarup Swaminathan, MD
Personalized Patient-Centered Glaucoma Management
Zarmeena Vendal, MD
SLT as First-Line Therapy
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Jordan Deaner
Vaidehi S. Dedania, MD
Rehan M. Hussain, MD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Outcomes for PDR Patients LTFU for at Least 1 Year
Kyle Davis Kovacs, MD
Matt Starr, MD
Nita Valikodath, MD, MS
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Maria H. Berrocal, MD
Lejla Vajzovic, MD, FASRS
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.